VICKIE JOHNSON: Open Payments
NPI 1922338086 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,200 in 28 payments from 13 companies in 2025. Trend: 2023 $1,822 · 2024 $1,227 · 2025 $2,200
Food & beverage: $2,200
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $420 |
| Janssen Biotech, Inc. | 5 | $254 |
| E.R. Squibb & Sons, L.L.C. | 2 | $252 |
| Axsome Therapeutics, Inc. | 2 | $242 |
| Janssen Pharmaceuticals, Inc | 3 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $127 |
| Ardelyx, Inc. | 1 | $127 |
| Madrigal Pharmaceuticals | 1 | $122 |
| ABBVIE INC. | 2 | $115 |
| Novo Nordisk Inc | 1 | $113 |
Products named: TREMFYA, COBENFY, Auvelity, INVEGA SUSTENNA, CAPLYTA, IBSRELA, REZDIFFRA, Wegovy.
Industry payments across MI — which companies pay providers there.
